Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavored IV Ondansetron Orally for Vomiting in Children
NCT02473887Phase 1Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Sep 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of ondansetron in gastroenteritis, sponsored by Hamad Medical Corporation. Primary endpoint: Ondansetron serum level at 4 hours. Started Sep 2014; status: completed.
02
Drugs
ondansetron
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on NCT02473887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473887.